PBL Assay Science's Interferon ELISA Kits are designed to be easily adopted in a regulated environment, with high reproducibility, good LLOQs and robust matrix tolerance (including autoimmune disease ...

To ensure uninterrupted availability of these four ELISA kits until completion of the asset transfer, IBL International GmbH, a Tecan company, has signed a Master Distributorship Agreement with Cisbio ...

To ensure uninterrupted availability of these four ELISA kits until completion of the asset transfer, IBL International GmbH, a Tecan company, has signed a Master Distributorship Agreement with ...

The therapeutic potential of targeting glucagon-like peptide-1 (GLP-1) has become increasingly evident ... today announced an agreement to acquire certain assets relating to key ELISA immunoassay ...

P3NP-ELISA (N-Terminal Procollagen III Peptide ELISA)* – CE IVD ... The transition of these important ELISA kits marks a strategic step to expand the IBL specialty diagnostics portfolio under ...

The purchase includes the manufacturing process of four ELISA kits, two of which are in vitro diagnostic products ... ELISA test that measures the levels of N-terminal procollagen III peptide in serum ...

Current therapies fail to attenuate such complications. Here, we identify formyl-peptide receptor type 2 (FPR2) as a therapeutic target to treat heart and lung dysfunction associated with inflammatory ...

Study: Abilities of Rare Sugar Members to Release Glucagon-like Peptide-1 and Suppress Food ... anesthesia and analyzed using active GLP-1 ELISA kits. Food consumption after solution ...